A recent regulation proposed by the New Jersey Attorney General might affect the state's availability of clinical trials.
Germany’s Evotec has penned another deal amid a stream of R&D pacts over the past year, this time with PARP player Tesaro.
Science Exchange is providing its R&D service marketplace to QB3, the University of California incubator for life sciences startups.
Major CRO Parexel has teamed up with tech giant Microsoft to create a new cloud tech alliance, all aimed at speeding up drug research.
A year after launching its Japanese business, Clinigen has bought Japan’s largest supplier of unlicensed medicines.
Forge Therapeutics and Evotec have launched a discovery platform to develop novel antibiotics targeting metalloenzymes.
Novum Pharmaceutical Research Services has renovated its 34,000-square-foot early-phase clinic in Las Vegas.
A full 14 years after founding CRO Clinipace, its long-standing CEO and president, Jeff Williams, is planning to step down.
WuXi AppTec buys U.S.-based full-service CRO ResearchPoint Global, tapping the latter's clinical operations in over 60 countries.
Janssen has developed a mobile toolkit for trial supply management and patient engagement that can track adherence to each pill.